|
Quotes & Info
|
| CAPS > SEC Filings for CAPS > Form 8-K on 10-Feb-2009 | All Recent SEC Filings |
10-Feb-2009
Results of Operations and Financial Condition, Regulation FD Disclosure, Financia
The information in this Current Report, including the accompanying exhibit, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language contained in such filing.
On February 5, 2009, OrthoLogic Corp., dba. Capstone Therapeutics, announced by press release that it will host a teleconference and webcast to discuss operating plans on Tuesday, February 10, 2009 at 4:30pm EST/ 3:30pm CST/ 2:30pm MST/ 1:30pm PST. The call may be accessed at 888-256-9134 (domestic), (++)913-312-1387 (international); accompanying slides can be viewed by logging onto the Investors section of the Company's website, http://investor.capstonethx.com. A copy of the presentation "Capstone Therapeutics Overview and Corporate Development Strategy February 2009" is attached as Exhibit 99.1 and is incorporated by reference herein.
The information in this Current Report, including the accompanying exhibit, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language contained in such filing.
On February 5, 2009, OrthoLogic Corp., dba. Capstone Therapeutics, announced by press release that it will host a teleconference and webcast to discuss operating plans on Tuesday, February 10, 2009 at 4:30pm EST/ 3:30pm CST/ 2:30pm MST/ 1:30pm PST. The call may be accessed at 888-256-9134 (domestic), (++)913-312-1387 (international); accompanying slides can be viewed by logging onto the Investors section of the Company's website, http://investor.capstonethx.com. A copy of the presentation "Capstone Therapeutics Overview and Corporate Development Strategy February 2009" is attached as Exhibit 99.1 and is incorporated by reference herein.
(d) Exhibits
99.1 Capstone Therapeutics Overview and Corporate Development Strategy February 2009.
|
|